Cargando…

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial

Detalles Bibliográficos
Autores principales: Heinzel, Andreas, Schrezenmeier, Eva, Regele, Florina, Hu, Karin, Raab, Lukas, Eder, Michael, Aigner, Christof, Jabbour, Rhea, Aschauer, Constantin, Stefanski, Ana-Luisa, Dörner, Thomas, Budde, Klemens, Reindl-Schwaighofer, Roman, Oberbauer, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589419/
https://www.ncbi.nlm.nih.gov/pubmed/36300193
http://dx.doi.org/10.3389/fmed.2022.1048395
_version_ 1784814300759588864
author Heinzel, Andreas
Schrezenmeier, Eva
Regele, Florina
Hu, Karin
Raab, Lukas
Eder, Michael
Aigner, Christof
Jabbour, Rhea
Aschauer, Constantin
Stefanski, Ana-Luisa
Dörner, Thomas
Budde, Klemens
Reindl-Schwaighofer, Roman
Oberbauer, Rainer
author_facet Heinzel, Andreas
Schrezenmeier, Eva
Regele, Florina
Hu, Karin
Raab, Lukas
Eder, Michael
Aigner, Christof
Jabbour, Rhea
Aschauer, Constantin
Stefanski, Ana-Luisa
Dörner, Thomas
Budde, Klemens
Reindl-Schwaighofer, Roman
Oberbauer, Rainer
author_sort Heinzel, Andreas
collection PubMed
description
format Online
Article
Text
id pubmed-9589419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95894192022-10-25 Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial Heinzel, Andreas Schrezenmeier, Eva Regele, Florina Hu, Karin Raab, Lukas Eder, Michael Aigner, Christof Jabbour, Rhea Aschauer, Constantin Stefanski, Ana-Luisa Dörner, Thomas Budde, Klemens Reindl-Schwaighofer, Roman Oberbauer, Rainer Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-10-10 /pmc/articles/PMC9589419/ /pubmed/36300193 http://dx.doi.org/10.3389/fmed.2022.1048395 Text en Copyright © 2022 Heinzel, Schrezenmeier, Regele, Hu, Raab, Eder, Aigner, Jabbour, Aschauer, Stefanski, Dörner, Budde, Reindl-Schwaighofer and Oberbauer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Heinzel, Andreas
Schrezenmeier, Eva
Regele, Florina
Hu, Karin
Raab, Lukas
Eder, Michael
Aigner, Christof
Jabbour, Rhea
Aschauer, Constantin
Stefanski, Ana-Luisa
Dörner, Thomas
Budde, Klemens
Reindl-Schwaighofer, Roman
Oberbauer, Rainer
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title_full Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title_fullStr Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title_full_unstemmed Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title_short Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
title_sort corrigendum: three-month follow-up of heterologous vs. homologous third sars-cov-2 vaccination in kidney transplant recipients: secondary analysis of a randomized controlled trial
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589419/
https://www.ncbi.nlm.nih.gov/pubmed/36300193
http://dx.doi.org/10.3389/fmed.2022.1048395
work_keys_str_mv AT heinzelandreas corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT schrezenmeiereva corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT regeleflorina corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT hukarin corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT raablukas corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT edermichael corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT aignerchristof corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT jabbourrhea corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT aschauerconstantin corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT stefanskianaluisa corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT dornerthomas corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT buddeklemens corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT reindlschwaighoferroman corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial
AT oberbauerrainer corrigendumthreemonthfollowupofheterologousvshomologousthirdsarscov2vaccinationinkidneytransplantrecipientssecondaryanalysisofarandomizedcontrolledtrial